Home Tags UBiome

Tag: uBiome

Everything we know about uBiome, the startup that convinced Silicon Valley that testing poop was worth $600 million, and then filed for bankruptcy ami...

uBiome's test promised insights into your health from a tiny sample of your poop. But problems mounted for the startup, and now it's shutting down.
The microbiome testing company uBiome has come under scrutiny after an FBI raid.

Bankrupt poop-testing startup uBiome is shutting down

The buzzy Silicon Valley startup is converting from chapter 11 to chapter 7 bankruptcy, which means it'll cease operations and liquidate. uBiome once convinced VCs that testing poop was worth $600 million.
The microbiome testing company uBiome has come under scrutiny after an FBI raid.

Dispensed: uBiome gets dumped by CVS, Jeffrey Epstein’s wacky plan to sell DNA data, and 19 unicorn startups to watch

Welcome to Dispensed, Business Insider's weekly roundup of healthcare, biotech, and pharma news. In this week's letter: CVS dumps uBiome, Epstein's plan to sequence people's genomes, and key unicorn healthcare startups to watch.
UBiome founders Zac Apte and Jessica Richman

Microbiome testing startup uBiome is the fourth largest startup to crash and burn in 2019. Here are the top 11 startups that have crumbled so far this...

Consumer robot maker Anki was the highest valued startup to go under so far in 2019, having raised more than $224 million in venture capital.
The microbiome testing company uBiome has come under scrutiny after an FBI raid.

Poop-testing startup uBiome was once valued at $600 million by Silicon Valley’s top VCs. It just filed for bankruptcy.

The poop-testing firm said it hopes to entice an investor to purchase it for its scientific knowledge. It also aims to sell its sole remaining product at CVS.
The microbiome testing company uBiome has come under scrutiny after an FBI raid.

Dispensed: Oscar’s first moves in Medicare Advantage, uBiome’s new board members, and Novartis’ CEO’s commitment to wearing je...

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
President Donald Trump speaks about lowering drug prices with Health and Human Services Secretary Alex Azar.

Dispensed: Layoffs at uBiome, why mental health funding is booming, and Microsoft’s bet on partnerships with Walgreens and Providence

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
Holmes arrives at court in California in January 2019.

Dispensed: A trial date for Elizabeth Holmes, new management at uBiome, and the primary care trends we’re tracking

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

Dispensed: Young blood startup is back, a scoop about CityMD, and telling remarks from Merck’s CEO

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
The microbiome testing company uBiome has come under scrutiny after an FBI raid.

The inside story at uBiome, disrupting Wall Street from within, and Peloton’s prospects

Here are the biggest business stories of the past week, ranging from the inside story on poop-testing startup uBiome, to highlights from our IGNITION: Finance event.